Opioid makers and distributors are fighting a novel New York State law that aims to collect hundreds of millions of dollars from the industry to help defray costs of the opioid crisis, with some companies reengineering their supply chain to avoid the new tax. Companies and trade groups have argued in three legal challenges filed in recent months that the law, which seeks $600 million over six years, is unconstitutional. They point to a lawsuit New York’s attorney general has already filed against major opioid industry players to recoup money for the state, and say the tax is an improper end-run around resolution of that case. (Sara Randazzo, Wall Street Journal)